Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Adam Kesner"'
Publikováno v:
EJNMMI Physics, Vol 6, Iss 1, Pp 1-6 (2019)
Abstract PET imaging has been, and continues to be, an evolving diagnostic technology. In recent years, the modernizing digital landscape has opened new opportunities for data-driven innovation. One such facet has been data-driven motion correction (
Externí odkaz:
https://doaj.org/article/37c05867278c485ca5792adc68063fc6
Autor:
Nicola Naydenov, Alexei Teplov, Mahdi Zadeh Zirakchian, Shutian Ruan, Bae P. Chu, Brian Serencsits, Marisa Iraca, Olga Talarico, Brian Miller, Henry Kunin, Jazmin Schwartz, Adam Kesner, Lars R. Furenlid, Larry Dauer, Yukako Yagi, John L. Humm, Pat Zanzonico, Constantinos T. Sofocleous, Assen S. Kirov
Publikováno v:
Journal of Vascular and Interventional Radiology.
Autor:
Adam Kesner
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 49:436-442
Autor:
Lukas M. Carter, Simone Krebs, Adam Kesner, Chan Hyeong Kim, Chansoo Choi, Heiko Schöder, Bradley J. Beattie, Wesley E. Bolch
Publikováno v:
Journal of Nuclear Medicine. 62:1805-1814
Despite the known influence of anatomic variability on internal dosimetry, dosimetry for 18F-FDG and other diagnostic radiopharmaceuticals is routinely derived using reference phantoms, which embody population-averaged morphometry for a given age and
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63(10)
The application of radiopharmaceutical therapy for the treatment of certain diseases is well established, and the field is expanding. New therapeutic radiopharmaceuticals have been developed in recent years, and more are in the research pipeline. Con
Autor:
Adam Kesner
Publikováno v:
J Nucl Med
The impact of PET image acquisition and reconstruction parameters on SUV measurements or radiomic feature values is widely documented. This scanner effect is detrimental to the design and validation of predictive or prognostic models and limits the u
Autor:
Craig S. Levin, Ramsey D. Badawi, Nicolas Aide, Kevin M. Bradley, Daniel R. McGowan, Andrei Iagaru, Simon R. Cherry, Irene Buvat, Ken Hermann, Charline Lasnon, Adam Kesner
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2021, 48 (9), pp.2711-2726. ⟨10.1007/s00259-021-05390-4⟩
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2021, 48 (9), pp.2711-2726. ⟨10.1007/s00259-021-05390-4⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af4bdbba67d0a260ed5a46a1472dfba3
https://ora.ox.ac.uk/objects/uuid:631ebd52-168a-42dd-beb4-6120accf2f98
https://ora.ox.ac.uk/objects/uuid:631ebd52-168a-42dd-beb4-6120accf2f98
Autor:
Jennifer J. Kwak, Martin D. McCarter, Phillip J. Koo, Alexandria Jensen, Chloe Friedman, Adam Kesner, Rustain Morgan, Ana Gleisner, Nicole Kounalakis
Publikováno v:
Annals of Surgical Oncology. 27:1432-1438
To investigate the use of advanced SPECT/CT quantification in guiding surgical selection of positive sentinel lymph nodes (SLNs) in head and neck melanoma. We retrospectively reviewed data from patients with cutaneous head and neck melanoma who under
Autor:
Jason S. Lewis, Lukas M. Carter, Suzanne E. Lapi, Adriana V.F. Massicano, Corey Cutler, Vanessa A. Sanders, Edwin C. Pratt, Adam Kesner
Publikováno v:
Mol Imaging Biol
PURPOSE: The increasing interest and availability of non-standard positron-emitting radionuclides has heightened the relevance of radionuclide choice in the development and optimization of new positron emission tomography (PET) imaging procedures, bo
Autor:
Michael R. McDevitt, Sarah M. Cheal, Brian H. Santich, Blesida Punzalan, Darren R. Veach, Simone Krebs, Guangbin Yang, Sebastien Monette, Thomas Z. Kubik, Lukas M. Carter, Steven M. Larson, Megan M. Dacek, Daniela Burnes Vargas, Nai-Kong V. Cheung, Ouathek Ouerfelli, David A. Scheinberg, Adam Kesner
Publikováno v:
Bioconjug Chem
Pretargeted imaging and radioimmunotherapy approaches are designed to have superior targeting properties over directly targeted antibodies but impose more complex pharmacology, which hinders efforts to optimize the ligands prior to human applications